Trial
NCT03822455
A Phase 2b Randomised, Placebo Controlled Study of OligoG in Patients with Cystic Fibrosis
Phase IITERMINATEDEFFICACY/FUTILITYConfidence: HIGH
Sponsor
AlgiPharma AS
Collaborators
—
Condition
Cystic Fibrosis
Intervention
OligoG DPI
Why stopped
Futility
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-10-28